141 related articles for article (PubMed ID: 9258412)
1. ACAT inhibitor HL-004 accelerates the regression of hypercholesterolemia in stroke-prone spontaneously hypertensive rats (SHRSP): stimulation of bile acid production by HL-004.
Murakami S; Yamagishi I; Sato M; Tomisawa K; Nara Y; Yamori Y
Atherosclerosis; 1997 Aug; 133(1):97-104. PubMed ID: 9258412
[TBL] [Abstract][Full Text] [Related]
2. Hypolipidemic and antiatherosclerotic effects of a novel ACAT inhibitor, HL-004, in stroke-prone spontaneously hypertensive rats.
Murakami S; Nara Y; Yamori Y
Exp Mol Pathol; 1995 Aug; 63(1):23-32. PubMed ID: 8759051
[TBL] [Abstract][Full Text] [Related]
3. Taurine accelerates the regression of hypercholesterolemia in stroke-prone spontaneously hypertensive rats.
Murakami S; Nara Y; Yamori Y
Life Sci; 1996; 58(19):1643-51. PubMed ID: 8632701
[TBL] [Abstract][Full Text] [Related]
4. Acyl-coenzyme A:cholesterol acyltransferase inhibitor, avasimibe, stimulates bile acid synthesis and cholesterol 7alpha-hydroxylase in cultured rat hepatocytes and in vivo in the rat.
Post SM; Zoeteweij JP; Bos MH; de Wit EC; Havinga R; Kuipers F; Princen HM
Hepatology; 1999 Aug; 30(2):491-500. PubMed ID: 10421659
[TBL] [Abstract][Full Text] [Related]
5. Effects of HL-004, a novel ACAT inhibitor, on cholesterol accumulation and removal in cultured smooth muscle cells from stroke-prone spontaneously hypertensive rats (SHRSP).
Murakami S; Araki H; Otomo S; Nara Y; Yamori Y
Life Sci; 1995; 56(7):509-20. PubMed ID: 7869831
[TBL] [Abstract][Full Text] [Related]
6. The hypolipidemic action of the ACAT inhibitor HL-004 in hamsters fed normal chow.
Murakami S; Ohta Y; Asami Y; Yamagishi I; Toda Y; Sato M; Tomisawa K
Gen Pharmacol; 1996 Dec; 27(8):1383-6. PubMed ID: 9304411
[TBL] [Abstract][Full Text] [Related]
7. The ACAT inhibitor HL-004 inhibits cholesterol absorption and lowers serum cholesterol in rats.
Asami Y; Kondo Y; Murakami S; Araki H; Tsuchida K; Higuchi S
Gen Pharmacol; 1998 Oct; 31(4):593-6. PubMed ID: 9792221
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological profile of F 12511, (S)-2',3', 5'-trimethyl-4'-hydroxy-alpha-dodecylthioacetanilide a powerful and systemic acylcoenzyme A: cholesterol acyltransferase inhibitor.
Junquero D; Oms P; Carilla-Durand E; Autin J; Tarayre J; Degryse A; Patoiseau J; Colpaert FC; Delhon A
Biochem Pharmacol; 2001 Jan; 61(1):97-108. PubMed ID: 11137714
[TBL] [Abstract][Full Text] [Related]
9. Effect of the ACAT inhibitor, HL-004, on cholesterol metabolism in macrophages.
Murakami S; Yamagishi I; Asami Y; Sato M; Tomisawa K
Cell Mol Biol (Noisy-le-grand); 1996 Sep; 42(6):865-72. PubMed ID: 8891354
[TBL] [Abstract][Full Text] [Related]
10. [Studies on stroke-prone spontaneously hypertensive rats (SHRSP) fed a high-fat and high-cholesterol diet--effect of taurine on serum lipoprotein metabolism in hypercholesterolemic rats].
Ogawa H; Nishikawa T; Fukushima S; Sasagawa S
Nihon Eiseigaku Zasshi; 1989 Jun; 44(2):648-58. PubMed ID: 2810865
[TBL] [Abstract][Full Text] [Related]
11. In vivo evidence that the lipid-regulating activity of the ACAT inhibitor CI-976 in rats is due to inhibition of both intestinal and liver ACAT.
Krause BR; Anderson M; Bisgaier CL; Bocan T; Bousley R; DeHart P; Essenburg A; Hamelehle K; Homan R; Kieft K
J Lipid Res; 1993 Feb; 34(2):279-94. PubMed ID: 8429262
[TBL] [Abstract][Full Text] [Related]
12. Hypolipidemic effect of taurine in stroke-prone spontaneously hypertensive rats.
Murakami S; Yamagishi I; Asami Y; Ohta Y; Toda Y; Nara Y; Yamori Y
Pharmacology; 1996 May; 52(5):303-13. PubMed ID: 8807674
[TBL] [Abstract][Full Text] [Related]
13. Taurine ameliorates cholesterol metabolism by stimulating bile acid production in high-cholesterol-fed rats.
Murakami S; Fujita M; Nakamura M; Sakono M; Nishizono S; Sato M; Imaizumi K; Mori M; Fukuda N
Clin Exp Pharmacol Physiol; 2016 Mar; 43(3):372-8. PubMed ID: 26710098
[TBL] [Abstract][Full Text] [Related]
14. Demonstration of a direct effect on hepatic acyl CoA: cholesterol acyl transferase (ACAT) activity by an orally administered enzyme inhibitor in the hamster.
Burrier RE; Deren S; McGregor DG; Hoos LM; Smith AA; Davis HR
Biochem Pharmacol; 1994 Apr; 47(9):1545-51. PubMed ID: 8185666
[TBL] [Abstract][Full Text] [Related]
15. Stimulation of cholesterol release from rabbit foam cells by the action of a new inhibitor for acyl CoA:cholesterol acyltransferase (ACAT), HL-004.
Ishii I; Yokoyama N; Yanagimachi M; Ashikawa N; Hata M; Murakami S; Asami Y; Morisaki N; Saito Y; Ohmori S; Kitada M
J Pharmacol Exp Ther; 1998 Oct; 287(1):115-21. PubMed ID: 9765329
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological properties of YM17E, an acyl-CoA:cholesterol acyltransferase inhibitor, and diarrheal effect in beagle dogs.
Kashiwa M; Masuyama Y; Miyauchi H; Uchida T; Naganuma S; Kakuta H; Terada M; Kiriyama T; Matsuda K; Ito N; Iizumi Y; Takenaka T
Jpn J Pharmacol; 1997 Jan; 73(1):41-50. PubMed ID: 9032133
[TBL] [Abstract][Full Text] [Related]
17. HL-004, the ACAT inhibitor, prevents the progression of atherosclerosis in cholesterol-fed rabbits.
Asami Y; Yamagishi I; Murakami S; Araki H; Tsuchida K; Higuchi S
Life Sci; 1998; 62(12):1055-63. PubMed ID: 9519807
[TBL] [Abstract][Full Text] [Related]
18. Hypertension in rats does not potentiate hypercholesterolemia and aortic cholesterol deposition induced by a hypercholesterolemic diet.
Mori H; Ishiguro K; Okuyama H
Lipids; 1993 Feb; 28(2):109-13. PubMed ID: 8441335
[TBL] [Abstract][Full Text] [Related]
19. Plasma cholesterol reducing effect of FR129169, a novel acyl-CoA:cholesterol acyltransferase inhibitor, in the rat.
Sakuma Y; Hagihara H; Ohne K; Nagayoshi A; Mutoh S; Ito Y; Notsu Y; Okuhara M
Jpn J Pharmacol; 1996 Jan; 70(1):35-41. PubMed ID: 8822087
[TBL] [Abstract][Full Text] [Related]
20. U-73482: a novel ACAT inhibitor that elevates HDL-cholesterol, lowers plasma triglyceride and facilitates hepatic cholesterol mobilization in the rat.
Bell FP; Gammill RB; St John LC
Atherosclerosis; 1992 Feb; 92(2-3):115-22. PubMed ID: 1632844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
